Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Thailand
Management Report
Published: January 2010
Pages: 34
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Lax patent laws have brought widespread condemnation from industry players, and the compulsory licensing of drugs in 2006, 2007 and 2008 has exacerbated the situation. More compulsory licences are expected in the future.
The ’30 baht’ scheme, first implemented in 2001, is designed to bring universal healthcare coverage to the Thai population in the long term. It was replaced with a new universal healthcare coverage scheme in November 2006.
The largest domestic drug manufacturer in Thailand is the Government Pharmaceutical Office (GPO) which has a near monopoly over the public hospital sector in the country. Public hospitals are legally obliged to purchase 80% of their drugs from the GPO.
The pharmaceutical industry appears to be recovering, with both imports and exports showing impressive growth in recent years. The pharmaceutical market is projected to expand at a low double-digit CAGR between 2010 and 2015.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.
The ’30 baht’ scheme, first implemented in 2001, is designed to bring universal healthcare coverage to the Thai population in the long term. It was replaced with a new universal healthcare coverage scheme in November 2006.
The largest domestic drug manufacturer in Thailand is the Government Pharmaceutical Office (GPO) which has a near monopoly over the public hospital sector in the country. Public hospitals are legally obliged to purchase 80% of their drugs from the GPO.
The pharmaceutical industry appears to be recovering, with both imports and exports showing impressive growth in recent years. The pharmaceutical market is projected to expand at a low double-digit CAGR between 2010 and 2015.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.